Stocks
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 14.1 | 18.1 | -455.8 | 18.6 | 9.67 | 26.5 | ||
| Changes by years, y/y, % | +44% | +29% | -2 622% | -104% | -48% | -0.2% | |||
ANI Pharmaceuticals. EV/EBITDA
ANI Pharmaceuticals. EV/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 11.3 | 10.5 | 12.4 | 12.0 | 25.6 | 26.5 | |
| Changes by years, y/y, % | -155% | -61% | -9% | -1% | +126% | |||
| Changes by quarters, q/q, % | -7% | -8% | +19% | -3% | +114% | |||
